Is The Emv Lens The Next Step In Lens Evolution For Demanding Patients With Imperfect Macula?

Intraocular lens (IOL) implantation is a common surgical procedure used to treat various ocular conditions, including cataracts and refractive errors. Multifocal IOLs are commonly used to correct presbyopia and provide patients with both distance and near vision. However, certain patient factors may preclude the use of multifocal IOLs, and alternative IOL options may be considered. The RayOne EMV IOL is a new, one-piece hydrophobic acrylic lens designed to provide excellent visual outcomes with minimal glare and halos. In this case, we want to show an EMV lens, as an alternative to monofocal lenses for patients with epiretinal membrane (ERM).

Department of Ophthalmology, Kornel Gibiński University Clinical Center, Medical University of Silesia, Katowice, Poland

We present a case report of a 59-year-old male who underwent bilateral cataract surgery with RayOne EMV IOL implantation. The patient had a history of epiretinal membrane (ERM) and was disqualified from receiving multifocal IOLs due to the potential for decreased contrast sensitivity and visual disturbances. Pre-operative visual acuity was significantly impaired in both eyes due to advanced cataracts (Right eye BCVA 20/40, left eye BCVA 20/50).

The surgery was performed under topical anesthesia, and the RayOne EMV IOL was implanted through a small incision using a standard phacoemulsification technique. Post-operative follow-up was conducted at regular intervals, and the patient's visual acuity (20/20) , refractive status, and any complications were documented. The RayOne EMV IOL provided the patient with improved distance and intermediate visual acuity without compromising contrast sensitivity or causing visual disturbances. The patient reported satisfaction with the visual outcome and absence of any post-operative complications.

This case report demonstrates the effectiveness and safety of the RayOne EMV IOL as an alternative to multifocal IOLs in patients with pre-existing retinal conditions. The RayOne EMV IOL may provide a viable option for patients who are disqualified from multifocal IOL implantation. These lenses could potentially replace monofocal lenses in the future, as a safe alternative for patients with retinal diseases.